ENCutaneous lymphoma is a tumour of lymphocytes that starts in the skin and stays there for a long time, and most patients arrive after years of treatment for “eczema”, “psoriasis” or “an allergy”: the patches fade under a steroid cream and return, and the thought of cancer comes last, sometimes years later.
Here is why this happens, how the diagnosis is confirmed in Germany, how skin-directed and systemic treatment differ and in which order they are used: the core of cutaneous lymphoma treatment in Germany. For lymphomas in general, see lymphoma treatment in Germany.
Why cutaneous lymphoma is taken for eczema for years
Because at first it looks like ordinary skin inflammation. In the commoner T-cell forms (B-cell ones are rarer), tumour T-lymphocytes live in the skin itself, giving not a lump but scaly pink patches or plaques, mostly on skin the sun does not reach. They look just like eczema, and a steroid cream brings partial improvement, adding to the confusion.
The commonest form is mycosis fungoides, a historical name unrelated to fungi. Sézary syndrome stands apart: almost the whole skin is involved and tumour cells are found in the blood. Quieter variants exist too: some CD30-positive lesions can come and go on their own.
An important distinction, plainly put: the skin can also be involved by a lymphoma that started in the lymph nodes, a different disease with a different approach; only the pathologist together with the dermatologist, using a full work-up, can tell them apart (see non-Hodgkin lymphoma). A clear German-language overview of lymphomas comes from the Krebsinformationsdienst of the German Cancer Research Center.
How the diagnosis is confirmed in Germany
The diagnosis rests on skin biopsy, and it is not a one-off procedure: early stages give a non-specific picture, so several samples are taken from different lesions and the biopsy is sometimes repeated months later. A detail patients rarely know: topical and systemic steroids are usually stopped for some weeks beforehand, or the picture blurs; the doctor sets the exact interval. See biopsy in Germany for the procedure itself.
Ordinary histology is supplemented by immunohistochemistry, staining that shows which markers cells carry, and a T-cell receptor clonality test, showing whether one and the same clone of lymphocytes has multiplied. If Sézary syndrome is suspected, the blood is also checked by flow cytometry, which counts marker-carrying cells.
Staging in cutaneous lymphoma differs from other lymphomas: it counts the area of skin involved, the type of lesions (patches, plaques, tumours or redness of almost the whole skin), the lymph nodes and the blood. Hence a practical point for travellers: bring not only the report but the slides and paraffin blocks, as they will be reviewed; if the review differs from the diagnosis made at home, consider a second opinion from a German doctor.
Skin-directed treatment
The main principle: while the disease stays in the skin, treatment starts with what acts on the skin, not the whole body. That means potent steroid ointments, other topical drugs such as chlormethine gel in mycosis fungoides, and phototherapy, narrowband ultraviolet B or PUVA (a light-sensitising substance plus irradiation), in courses several times a week.
For the trip, this matters: phototherapy is by definition spread over time and cannot be done in a week, so from the first appointment ask the doctor which part of the course is done in Germany and which can continue at home, and under whose supervision.
Individual thick lesions can be treated with local radiotherapy; for widespread disease there is total skin electron beam therapy, which not every hospital offers, so ask the particular centre rather than assume. The dermatology departments of German university hospitals are the natural place for this; see dermatology in Germany.
When systemic treatment is needed
Systemic drugs are added if the disease has moved beyond the skin, progresses quickly or does not respond to skin-directed treatment: interferon and retinoids; targeted antibodies against tumour-cell markers, mogamulizumab and, for CD30-positive forms, brentuximab vedotin, both used after previous systemic treatment; and for Sézary syndrome extracorporeal photopheresis, where the blood is passed through a device, treated with light and returned to the patient. Classic multi-drug chemotherapy is used more sparingly here than in nodal lymphomas and usually not first; see chemotherapy for lymphoma.
In severe cases a donor (allogeneic) stem cell transplant is discussed for individual patients. A board of dermato-oncologists and haematologists decides, and at this stage it matters particularly that one department leads the case, not two in parallel. Cutaneous lymphomas are managed in dermato-oncology departments: AlenMed’s partners include the Frankfurt University Hospital, where the Department of Dermatology, Venereology and Allergology is headed by Prof. Bastian Schilling, and the Cologne University Hospital with its Department of Dermatology and Venereology under Prof. Esther von Stebut.
Frequently asked questions
How long does cutaneous lymphoma treatment in Germany take?
There is no single duration: it depends on the form, the stage and the method. The doctor estimates the first stage, a slide review and sometimes a new biopsy, after studying the documents; phototherapy runs as a course over time, so part of it usually continues at home under a written plan.
How much does cutaneous lymphoma treatment in Germany cost?
There is no fixed price list: without an examination and a histology review, any figure would be unverified. The total depends on whether a new biopsy is needed, how much phototherapy takes place in Germany and whether systemic treatment is required; the guide is the hospital’s written estimate.
Can treatment be continued at home?
Often yes, if the German department draws up a clear plan: phototherapy or medication often continues closer to home on written instructions covering drug names, regimen and check-ups. The treating doctor in Germany decides which part can move home; the discharge letter is best translated in advance.
How AlenMed arranges treatment for cutaneous lymphoma
AlenMed starts with the documents: biopsy slides and blocks, pathology reports from all past years, lesion photographs, blood results and discharge letters go to a dermato-oncology department. The doctor answers whether the material needs reviewing, whether a new biopsy is required and how long the first stage will take; then come a written estimate, a visa invitation, an interpreter at appointments and a place for a companion.
Plan ahead: agree on stopping steroids before the biopsy, allow time for a course of phototherapy, ask for a written plan for continuing treatment at home with drug names and a monitoring schedule, and have the final discharge letter translated.
This material is for information only and is not an offer; the treatment approach is decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
